N. Sacks

发表

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.

B. Gusterson, S. Ebbs, S. Johnston, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen and HRT: Synergistic or Antagonistic?

N. Sacks, J. Marsden, N. Sacks, 1997 .

Assessment of a scoring system for breast imaging

R. Given-Wilson, V. Thomas, R M Given-Wilson, 1998, The British journal of surgery.

A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma.

S. Tan, D. King, G. Gui, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

M. Dowsett, J. Salter, R. A’Hern, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hormone Replacement Therapy in Women with Previous Breast Cancer

M. Baum, N. Sacks, J. Marsden, 1998, Trends in Endocrinology & Metabolism.

Reexcision operations in nonpalpable breast cancer

K. Mokbel, A. Nash, M. Ahmed, 1995, Journal of surgical oncology.

The Royal Marsden Hospital pilot tamoxifen chemoprevention trial

T. Powles, J. Davey, M. Baum, 2004, Breast Cancer Research and Treatment.

The management of women with a high risk of breast cancer

T. Powles, M. O'Brien, N. Sacks, 1996 .

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

M. Sporn, K. Maclennan, M. Dowsett, 1992, Cancer research.

Recent advances in the treatment of breast cancer.

N. Sacks, W. J. Smellie, 1994, Postgraduate medical journal.

The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.

R. Coombes, Y. Luqmani, J. Gazet, 1997, European journal of cancer.

Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.

J. Tjandra, S. Stacker, I. Mckenzie, 1988, British Journal of Cancer.

The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.

J. Tjandra, J. Collins, J. Andrews, 1989, British Journal of Cancer.

Risk-reducing mastectomy

N. Sacks, T. Davidson, 2004 .

Tamoxifen induces the expression of cytoplasmic c-erbB2 immunoreactivity in oestrogen-receptor positive breast carcinomas in-vivo

M. Dowsett, J. Salter, M. Baum, 1993 .

T-cell lymphoma in Hashimoto's thyroiditis.

H. Gogas, J. Tooze, J. Mansi, 1996, Histopathology.

Is mastectomy overtreatment for Paget's disease of the nipple?

N. Sacks, A. Singh, R. J. Sutton, 1999, Breast.

Multimodality therapy in inflammatory breast cancer: is there a place for surgery?

S. Ebbs, S. Johnston, I. Smith, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary medical (neoadjuvant) chemotherapy for operable breast cancer: Building on early promise

K. Maclennan, M. Dowsett, M. Baum, 1992 .

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

W. Allum, I. Smith, A. Ring, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.

S. Eccles, P. Garg, M. Zalutsky, 1995, Cancer research.

Comparison of biochemical aromatase activity with aromatase immunhistochemistry in human breast carcinomas

M. Dowsett, H. Sasano, M. Rowlands, 2004, Breast Cancer Research and Treatment.

Nipple Excised and Areola Retained after Total Mastectomy (NEAT)

G. Gui, N. Nasiri, N. Sacks, 2001, Journal of the Royal Society of Medicine.

The Detection of Micrometastases in the Peripheral Blood and Bone Marrow of Patients with Breast Cancer Using Immunohistochemistry and Reverse Transcriptase Chain Reaction for Keratin 19 Polymerase

Y. Luqmani, J. Gomm, N. Sacks, 1997 .

Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen.

M. Baum, S. Eccles, C. Dean, 1993, British Journal of Cancer.

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen.

K. Maclennan, M. Dowsett, J. Salter, 1994, European journal of cancer.

Short term tamoxifen induces the cytoplasmic expression of c-erbB2 and BCL-2 in er-positive human primary breast cancer

K. Maclennan, M. Dowsett, J. Salter, 1992 .

Axillary node dissection in breast cancer

I. Tannock, R. Huddart, A. Oza, 1992, The Lancet.

Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.

I. Ellis, R. Blamey, J. Robertson, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.

M. Dowsett, Z. Rayter, J. Salter, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary management of carcinoma of the breast

M. Baum, N. Sacks, 1993, The Lancet.

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

T. Hickish, A. Norman, M. Nicolson, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.

M. Dowsett, J. Salter, M. Hills, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

M. Dowsett, S. Ebbs, J. Salter, 2001, Cancer research.

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer

M. Dowsett, P. Ellis, J. Salter, 2003, British Journal of Cancer.

Role of axillary surgery in early breast cancer: review of the current evidence.

A. Spillane, N. Sacks, 2000, The Australian and New Zealand journal of surgery.

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

T. Powles, T. Hickish, A. Makris, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of axillary dissection in operable breast cancer

M. Baum, N. Sacks, L. Barr, 1992 .

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.

J. Collins, I. Russell, I. McKenzie, 1987, British Journal of Cancer.

Case report: Primary osteosarcoma of the breast: imaging and histological features.

R. Given-Wilson, A. L. Brown, V. Thomas, 1998, Clinical radiology.

Treatment and outcome of intracystic papillary carcinoma of the breast

G. Gui, N. Nasiri, N. Sacks, 1999, The British journal of surgery.

The impact of hormone replacement therapy on breast cancer patients' quality of life and sexuality: a pilot study

L. Fallowfield, M. Baum, R. A'hern, 2001 .

Erosive adenomatosis of the nipple--a report of three cases.

P. Trott, N. Sacks, G. Davies, 2004, Annals of the Royal College of Surgeons of England.

Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.

M. Baum, I. Smith, J. Mckinna, 1993, European journal of cancer.

Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.

J. Tjandra, S. Stacker, I. Mckenzie, 1988, Cancer research.

A Serum Test for the Diagnosis and Monitoring the Progress of Breast Cancer

S. Stacker, C. Smart, R. Burton, 1987 .

Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry

T. Powles, M. Dowsett, M. Nicolson, 2004, Virchows Archiv.

Immunocytochemical Staining For the C‐Erbb‐2 Gene Product In Breast Aspirates: A Preliminary Report

C. Dean, I. Fernando, J. Sandle, 1993, Cytopathology : official journal of the British Society for Clinical Cytology.

Catheter fracture: a rare complication of totally implantable venous devices.

S. Johnston, N. Sacks, N. Maisey, 2003, Breast.

The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update

N. Sacks, J. Marsden, 2001 .

Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer

M. Dowsett, M. Baum, B. Haynes, 1993, Breast Cancer Research and Treatment.

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.

P. Ellis, S. Ebbs, M. Baum, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How Much of the Effect of Chemotherapy Is Due to Hormonal Manipulation

M. Baum, R. A’Hern, N. Sacks, 1993 .

A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma (vol 28, pg 203, 2002)

S. Tan, D. King, G. Gui, 2002 .

The Role of Hormone Replacement Therapy and Alternative Treatments

N. Sacks, J. Marsden, 2004 .

The National Randomised Trial of Hormone Replacement Therapy in Women with a History of Early Stage Breast Cancer

N. Sacks, J. Marsden, 2001, The Journal of The British Menopause Society.

Comparison ofmammary serumantigen (MSA)andCA15-3levels inthe serumofpatients withbreast cancer

J. Collins, I. Russell, I. Mckenzie, 1987 .

Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy.

T. Powles, L. Assersohn, A. Nash, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.

S. Stacker, I. Mckenzie, N. Sacks, 1987, Developments in biological standardization.

Clinical radioimmunolocalization with a rat monoclonal antibody directed against c-erbB-2

S. Eccles, C. Dean, N. Sacks, 2007, Cell Biophysics.

Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?

M. Baum, R. A'hern, M. Whitehead, 2000, Fertility and sterility.

Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.

A. Harris, M. Greenall, Kenneth G. C. Smith, 1993, European journal of cancer.

Primary medical chemotherapy with continuous infusional 5-fu (F), epirubicin (E) and cisplatin (P) for large operable breast cancer: a very active new regimen

S. Ebbs, M. Baum, I. Smith, 1993 .

F170 A randomised controlled trial of hormone replacement therapy in breast cancer patients — A feasibility study

M. Baum, M. Whitehead, D. Crook, 1996 .